Cancer Center A Cancer Center Designated by
the National Cancer Institute

Clinical Trials in the Category "Brain Neoplasms"

Drug Intervention Trials that are Recruiting

Study Title
Principal Investigator Disease Category
Phase I Vorinostat Concurrent with Stereotactic Radiosurgery (SRS) in Brain Metastases from Non-Small Cell Lung Cancer John R. Adler
Brain Cancer
Neoplasm Metastasis
Lung Cancer
Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors Iris Catrice Gibbs
Brain Cancer
Phase 2 of Azixa™ (MPC-6827) for Glioblastoma Multiforme in First or Second Relapse Dr Lawrence Recht
Brain Cancer
Glioblastoma
Low-Dose Radiation Therapy and Combination Chemotherapy Following Surgery in Treating Children With Newly Diagnosed Primitive Neuroectodermal Tumor or Medulloblastoma Paul Graham Fisher
Central Nervous System Neoplasms
Brain Cancer
Neuroectodermal Tumors
Medulloblastoma
Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary CNS Germ Cell Tumor Dr. Neyssa Marina
Central Nervous System Neoplasms
Brain Cancer
Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma Sandra Jeane Horning
Brain Cancer
Lymphoma
Ph I Dose-Escalation of AEG40826-2HCI for Advanced Solid Tumors Branimir I Sikic
Brain Cancer
Cancer


Other Trials that are Recruiting

Study Title
Principal Investigator Disease Category
Phase I/II Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases Scott Soltys
Clara Choi
Brain Cancer
Neoplasm Metastasis

Trials not Recruiting

Study Title
Principal Investigator Disease Category
Molecular Genetic Studies of Childhood Brain Tumors and Blood Samples
(Completed)
James M Ford
Brain Cancer
Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma
(Completed)
Dr. Neyssa Maria Marina
Brain Cancer
Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma
(Completed)
Iris Catrice Gibbs
Brain Cancer
Assessing the suitability of an imaging probe for use in clinical cell and gene therapy trials in cancer and rheumatoid arthritis
(No longer recruiting)
Sanjiv Sam Gambhir M.D., Ph.D.
Central Nervous System Neoplasms
Brain Cancer
Glioma
Arthritis, Rheumatoid
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma
(No longer recruiting)
Dr. Neyssa Marina
Central Nervous System Neoplasms
Ependymoma
Brain Cancer
Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors
(No longer recruiting)
Dr. Neyssa Marina
Central Nervous System Neoplasms
Neoplasms, Germ Cell and Embryonal
Brain Cancer
XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors
(Completed)
Dr Lawrence Recht
Brain Cancer
n Edema
Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
(No longer recruiting)
Dr. Neyssa Marina
Central Nervous System Neoplasms
Brain Cancer
Glioma
An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies
(Completed)
Dr Lawrence Recht
Brain Cancer
XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema
(No longer recruiting)
Dr Lawrence Recht
Brain Cancer
n Edema
Phase II/III Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III)
(No longer recruiting)
Dr Lawrence Recht
Central Nervous System Neoplasms
Brain Cancer
Glioblastoma


The physicians of the Stanford Cancer Center are engaged in more than 250 clinical trials.  Contracts with some of our clinical trial sponsors prevent us from listing specific trial information on our web site. Please contact the Stanford Cancer Clinical Trials Office at 650-498-7061 for information about additional open clinical trials.

Stanford Medicine Resources:

Footer Links: